ARL3 and neoplasm: In vivo tumorigenicity assays demonstrated that ARL3‐KO cells exhibited profoundly attenuated tumor growth, with xenografts displaying significant reductions in both volumetric expansion (Figure 2I,J) and final tumor weight (Figure 2K) compared to controls.